Form 4 for TRDA Entrada Therapeutics, Inc.
Accepted 2025-07-11 00:00:00 ET · period of report 2025-07-09 · accession 0001415889-25-019680 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-07-11 | 2025-07-09 | TRDA | PARMAR KUSH | Dir, 10% | S - Sale | $7.50 | -27.0K | 1.09M | -2% | -$202.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-09 | S | D | 20,065 | $7.50 | 3,163,066 | I By 5AM Ventures V, L.P. | — | — | (F1) Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein. |
| 2 | Common | Common Stock | 2025-07-09 | S | D | 6,935 | $7.50 | 1,093,313 | I By 5AM Opportunities I, L.P. | — | — | (F2) Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein. |